TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $329 | +5.4% | 20,000 | 0.0% | 0.38% | -13.5% |
Q4 2022 | $312 | -99.9% | 20,000 | -55.6% | 0.44% | +7.9% |
Q3 2022 | $583,000 | -74.8% | 45,000 | -73.5% | 0.40% | -67.4% |
Q4 2021 | $2,310,000 | -51.5% | 169,500 | -41.7% | 1.24% | -44.0% |
Q3 2021 | $4,762,000 | +71.9% | 290,753 | +76.6% | 2.21% | +99.8% |
Q2 2021 | $2,770,000 | +47.3% | 164,610 | +59.8% | 1.11% | +57.8% |
Q1 2021 | $1,880,000 | +105.9% | 102,988 | +101.1% | 0.70% | +81.6% |
Q3 2020 | $913,000 | +234.4% | 51,200 | +184.4% | 0.39% | +85.6% |
Q1 2020 | $273,000 | – | 18,000 | +1799900.0% | 0.21% | – |
Q3 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
Q2 2019 | $38,000 | -97.8% | 2,200 | -97.4% | 0.01% | -98.1% |
Q1 2019 | $1,714,000 | +171300.0% | 84,146 | +140143.3% | 0.59% | – |
Q4 2018 | $1,000 | -100.0% | 60 | -100.0% | 0.00% | -100.0% |
Q3 2018 | $3,123,000 | +66.9% | 146,156 | +63.1% | 0.73% | -2.0% |
Q2 2018 | $1,871,000 | – | 89,600 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |